HC Wainwright Has Optimistic View of Balchem FY2024 Earnings

Balchem Co. (NASDAQ:BCPC) – Equities research analysts at HC Wainwright increased their FY2024 EPS estimates for Balchem in a report released on Monday, November 4th. HC Wainwright analyst R. Selvaraju now expects that the basic materials company will post earnings of $4.01 per share for the year, up from their prior forecast of $3.81. HC Wainwright has a “Buy” rating and a $190.00 price objective on the stock. The consensus estimate for Balchem’s current full-year earnings is $4.09 per share. HC Wainwright also issued estimates for Balchem’s Q4 2024 earnings at $1.10 EPS, Q1 2025 earnings at $1.06 EPS, Q2 2025 earnings at $1.09 EPS, Q3 2025 earnings at $1.14 EPS, Q4 2025 earnings at $1.19 EPS and FY2025 earnings at $4.47 EPS.

Separately, StockNews.com upgraded shares of Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th.

Balchem Trading Up 4.6 %

BCPC stock opened at $183.41 on Wednesday. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. Balchem has a twelve month low of $116.84 and a twelve month high of $186.03. The stock has a market capitalization of $5.96 billion, a price-to-earnings ratio of 49.30, a price-to-earnings-growth ratio of 5.25 and a beta of 0.65. The firm’s fifty day simple moving average is $171.99 and its two-hundred day simple moving average is $163.77.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. nVerses Capital LLC bought a new position in shares of Balchem in the third quarter worth about $35,000. Bessemer Group Inc. grew its holdings in shares of Balchem by 568.9% in the first quarter. Bessemer Group Inc. now owns 301 shares of the basic materials company’s stock worth $47,000 after purchasing an additional 256 shares during the last quarter. Blue Trust Inc. lifted its stake in Balchem by 642.5% in the third quarter. Blue Trust Inc. now owns 839 shares of the basic materials company’s stock worth $148,000 after acquiring an additional 726 shares during the period. GAMMA Investing LLC lifted its stake in Balchem by 73.4% in the third quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company’s stock worth $148,000 after acquiring an additional 356 shares during the period. Finally, Private Advisor Group LLC purchased a new stake in Balchem in the third quarter worth about $220,000. 87.91% of the stock is currently owned by institutional investors.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.